Invasive aspergillosis in relapsed/refractory acute myeloid leukaemia patients: Results from SEIFEM 2016-B survey.
Maria Ilaria Del PrincipeGiulia DragonettiAllegra ContiLuisa VergaStelvio BallantiRosa FanciAnna CandoniFrancesco MarchesiChiara CattaneoFederica LessiNicola FracchiollaAngelica SpolzinoLucia PreziosoMario DeliaLeonardo PotenzaNunzia DecembrinoCarlo CastagnolaGianpaolo NadaliMarco PicardiDaniele ZamaEnrico OrciuloBarbara VeggiaMariagrazia GarziaMichelina DargenioLorella MelilloSara ManettaDomenico RussoValentina ManciniMonica PiedimonteMaria Chiara TisiNicola ToschiAlessandro BuscaLivio Paganonull nullnull nullPublished in: Mycoses (2021)
Our data demonstrated that the incidence of IA during the salvage chemotherapy is similar to the past. Nevertheless, the attributable mortality rate (AMR) appears to be lower than that previously reported in R/R AML. Further prospective studies should be performed to confirm our preliminary observation and understand and the why a decreased AMR is reported in this setting of high-risk patients.
Keyphrases
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- acute myeloid leukemia
- prognostic factors
- peritoneal dialysis
- risk factors
- type diabetes
- machine learning
- immune response
- patient reported outcomes
- coronary artery disease
- intensive care unit
- cardiovascular disease
- electronic health record
- cardiovascular events
- allogeneic hematopoietic stem cell transplantation
- drug induced
- hepatitis b virus
- antimicrobial resistance